Ovarian cancer is one of the common gynecological malignancies worldwide. It is usually diagnosed at a later stage, thus missing the best opportunity for treatment. Despite the advancement of ovarian cancer treatment, the prognosis is still poor. Androgen receptor (AR) may play a role in ovarian carcinogenesis. Previous studies regarding the association between AR CAG repeat length and ovarian cancer risk reported inconsistent results. Therefore, we conducted a meta-analysis to evaluate the association between AR CAG repeat length and ovarian cancer risk following the MOOSE guidelines. PubMed, Web of Science, EBSCO and other databases were searched up to September 15th 2016. Case control studies with clear definition of CAG repeat length and detailed genotype information were included. Two authors independently reviewed and extracted data. Pooled analysis and subgroup analysis stratified by ethnicity were performed for different genetic models. Begg's funnel plot and Egger's test were performed for publication bias estimation. Overall, there was no association between the AR CAG repeat polymorphism and ovarian cancer risk. However, short CAG repeat polymorphism was associated with increased ovarian cancer risk in African Americans and Chinese under the dominant model, whereas a reverse association was observed in Caucasians and Italians under the other three models. Our study results should be interpreted with caution. Further well-designed epidemiological and functional studies are needed to elucidate the role of AR in ovarian carcinogenesis.
[1]Taishan Med Univ, Sch Publ Hlth, Dept Epidemiol, Tai An, Shandong, Peoples R China.
[2]Fudan Univ, Obstet & Gynecol Hosp, Off Clin Epidemiol, 419 Fangxie Rd, Shanghai 200011, Peoples R China.
[3]Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol,IBS, Shanghai, Peoples R China.
[4]Fudan Univ, Acad Integrat Med, Shanghai, Peoples R China.
[5]Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China.
(8.0+极速模式)